Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy
Clinical trial NCT00702052 · COMPLETED
Trial details
- NCT number
- NCT00702052
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-22
- Primary completion
- 2012-04-20
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.